Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01154699 · ClinicalTrials.gov registry record · NA

Positive Airway Pressure for the Treatment of Asthma

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT01154699 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01154699, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

Asthma is an extremely common disorder, which is becoming more prevalent. The purpose of this study is to examine how nocturnal lung volumes contribute to asthma severity, which may explain part of the link between asthma and obesity. The investigators seek to test the hypothesis that raising lung volumes during the night will improve asthma symptoms. The investigators work may lead to new targets for therapy.

Interventions

  • DEVICE Bilevel PAP (4 weeks)
  • OTHER Usual Care (4 weeks)
  • OTHER Washout Period (4 weeks)

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2010-07
Est. Completion 2014-12
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT01154699

The ClinicalTrials.gov registry entry for NCT01154699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Bilevel PAP (4 weeks) is the first listed.

NCT01154699 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01154699 about?

NCT01154699 is a clinical study titled "Positive Airway Pressure for the Treatment of Asthma". Asthma is an extremely common disorder, which is becoming more prevalent. The purpose of this study is to examine how nocturnal lung volumes contribute to asthma severity, which may explain part of the link between asthma and obesity. The investigators seek to test the hypothesis that raising lung v...

What is the current status of trial NCT01154699?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2010-07. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01154699?

The interventions under investigation include: Bilevel PAP (4 weeks) (DEVICE), Usual Care (4 weeks) (OTHER), Washout Period (4 weeks) (OTHER).

Who is sponsoring clinical trial NCT01154699?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.